Cytotec (Misoprostol) 200-100mcg
Termination of pregnancy associated with fetal death or incompatible with the life of fetal malformation is an extremely difficult task for health workers in all countries. Besides theoretical obospokoennosti about the fact that the dead fetus in the womb causes disseminated intravascular coagulation, the continuation of such a pregnancy for many women is not acceptable with any psychological or social point of view. Therefore, a woman and her doctor leading both want to see the completion of a pregnancy as soon as possible, preferably without the uterine incision. Buy Cytotec online in India.
Misoprostol is a drug for the treatment of stomach ulcers and is not registered for pregnancy termination in many countries around the world. Ironically, it was he who made a revolution in the termination of pregnancy because of its wide availability and ease of use. Its properties remain stable at room temperature, making it a valuable drug for countries with limited resources. However, when used in pregnant women raises concerns uterine hyperstimulation and, in extreme cases - uterine rupture. Despite the fact that hyperstimulation, leading to utero-placental insufficiency, and is not a major problem in the induction of labor to terminate pregnancy in the second or third trimester in women with a malformation of the fetus, or intrauterine fetal death, the possibility of uterine rupture causes the most concern when it is used . Therefore, in this review comparing the benefits and adverse effects of misoprostol in comparison with other methods of induction of labor to terminate pregnancy in the second and third trimester pregnant women with developmental disabilities or death of the fetus.
Although this systematic review included all relevant randomized controlled trials of acceptable quality, it does not answer the most difficult question, syazanny with misoprostol, namely, uterine rupture during labor induction in the second and third trimester. This is due to a small sample size of the included studies, either because they are few reports about such outcomes. In addition to problems with the sample size, only a few studies (4-6 of 38) included in the review, there were women in the third trimester of pregnancy. On these terms the risk of uterine rupture increases. Therefore, you need to be very careful about the use of findings of this review in the third trimester. As I mentioned above, since it was impossible to carry out the analysis of subgroups, again due to the small sample sizes, the results may differ in women with uterine cicatricial changes, regardless of gestational age, which is performed in interruption.
Termination of pregnancy associated with fetal death or incompatible with the life of fetal malformation is an extremely difficult task for health workers in all countries. Besides theoretical obospokoennosti about the fact that the dead fetus in the womb causes disseminated intravascular coagulation, the continuation of such a pregnancy for many women is not acceptable with any psychological or social point of view. Therefore, a woman and her doctor leading both want to see the completion of a pregnancy as soon as possible, preferably without the uterine incision.
Misoprostol is a drug for the treatment of stomach ulcers and is not registered for pregnancy termination in many countries around the world. Ironically, it was he who made a revolution in the termination of pregnancy because of its wide availability and ease of use. Its properties remain stable at room temperature, making it a valuable drug for countries with limited resources. However, when used in pregnant women raises concerns uterine hyperstimulation and, in extreme cases - uterine rupture. Despite the fact that hyperstimulation, leading to utero-placental insufficiency, and is not a major problem in the induction of labor to terminate pregnancy in the second or third trimester in women with a malformation of the fetus, or intrauterine fetal death, the possibility of uterine rupture causes the most concern when it is used . Therefore, in this review comparing the benefits and adverse effects of misoprostol in comparison with other methods of induction of labor to terminate pregnancy in the second and third trimester pregnant women with developmental disabilities or death of the fetus.
Although this systematic review included all relevant randomized controlled trials of acceptable quality, it does not answer the most difficult question, syazanny with misoprostol, namely, uterine rupture during labor induction in the second and third trimester. This is due to a small sample size of the included studies, either because they are few reports about such outcomes. In addition to problems with the sample size, only a few studies (4-6 of 38) included in the review, there were women in the third trimester of pregnancy. On these terms the risk of uterine rupture increases. Therefore, you need to be very careful about the use of findings of this review in the third trimester. As I mentioned above, since it was impossible to carry out the analysis of subgroups, again due to the small sample sizes, the results may differ in women with uterine cicatricial changes, regardless of gestational age, which is performed in interruption.
भ्रूण कुरूपता के जीवन के साथ भ्रूण की मृत्यु या असंगत के साथ जुड़े गर्भावस्था की समाप्ति के सभी देशों में स्वास्थ्य कार्यकर्ताओं के लिए एक बहुत ही मुश्किल काम है। तथ्य यह है कि गर्भ कारणों में मृत भ्रूण intravascular जमावट फैलाया के बारे में सैद्धांतिक obospokoennosti इसके अलावा, कई महिलाओं के लिए इस तरह के एक गर्भावस्था की निरंतरता देखने के किसी भी मनोवैज्ञानिक या सामाजिक बिंदु के साथ स्वीकार्य नहीं है। इसलिए, एक महिला और उसके चिकित्सक दोनों प्रमुख अधिमानतः गर्भाशय चीरा बिना, जितनी जल्दी हो सके एक गर्भावस्था के पूरा होने देखना चाहते हैं।
Misoprostol पेट के अल्सर के उपचार के लिए एक दवा है और दुनिया भर के कई देशों में गर्भावस्था समाप्ति के लिए पंजीकृत नहीं है। विडंबना यह है कि यह वह था जो क्योंकि इसकी व्यापक उपलब्धता और उपयोग में आसानी के गर्भ का समापन में एक क्रांति बना दिया। इसके गुणों कमरे के तापमान पर स्थिर बने हुए हैं, यह सीमित संसाधनों के साथ देशों के लिए एक मूल्यवान दवा बना रही है। गर्भाशय टूटना - हालांकि, जब गर्भवती महिलाओं में इस्तेमाल चिंताओं गर्भाशय hyperstimulation और, कई मामलों में उठाती है। तथ्य यह है कि hyperstimulation के बावजूद, गर्भाशय-अपरा करने कमी अग्रणी है, और भ्रूण की कुरूपता, या अंतर्गर्भाशयी भ्रूण की मौत के साथ महिलाओं में दूसरी या तीसरी तिमाही में गर्भ को समाप्त करने के लिए श्रम की प्रेरण में एक बड़ी समस्या नहीं है, गर्भाशय संबंध विच्छेद की संभावना है जब यह प्रयोग किया जाता है सबसे अधिक चिंता का कारण बनता है । इसलिए, इस समीक्षा में श्रम की प्रेरण के अन्य तरीकों के साथ तुलना में लाभ और misoprostol के प्रतिकूल प्रभाव की तुलना विकास विकलांग या भ्रूण की मौत के साथ दूसरे और तीसरे तिमाही गर्भवती महिलाओं में गर्भ को समाप्त करने के लिए।
हालांकि इस व्यवस्थित समीक्षा स्वीकार्य गुणवत्ता के सभी प्रासंगिक यादृच्छिक नियंत्रित परीक्षण शामिल है, यह सबसे मुश्किल सवाल दूसरी और तीसरी तिमाही में श्रम प्रेरण दौरान misoprostol, अर्थात्, गर्भाशय टूटना साथ syazanny का जवाब नहीं है। यह शामिल अध्ययन का एक छोटा सा नमूना आकार की वजह से है, क्योंकि या तो वे इस तरह के परिणामों के बारे में कुछ खबरें हैं। नमूना आकार के साथ समस्याओं के अलावा, केवल कुछ अध्ययनों (38 के 4-6), समीक्षा में शामिल वहाँ गर्भावस्था की तीसरी तिमाही में महिलाओं के थे। इन शर्तों पर गर्भाशय टूटना का खतरा बढ़ जाता। इसलिए, आप तीसरी तिमाही में इस समीक्षा के निष्कर्षों के उपयोग के बारे में बहुत सावधान रहने की जरूरत है। मैं ऊपर उल्लेख किया है, क्योंकि यह छोटा सा नमूना आकार के कारण फिर से, उपसमूहों के विश्लेषण के लिए बाहर ले जाने के लिए असंभव था, परिणाम महिलाओं में गर्भाशय cicatricial परिवर्तन के साथ अलग हो सकता है, गर्भ की आयु, जो रुकावट में किया जाता है की परवाह किए बिना।